Waiver - BWC_RQ3 - Integrated DNA Technologies (ArcherDX) - Analysis Credits for Cancer Service
- Birmingham Women's and Children's NHS Foundation Trust
- West Midlands
- Direct award
- 1 August 2026 to 31 July 2027
Supply of digital analysis credits for ArcherDX genomic sequencing platforms used within clinical cancer services. This contract provides the necessary computational processing capacity for diagnostic workflows, ensuring continued access to proprietary analysis pipelines for oncology testing.
- Awarded value
- £50k
- As published
- Published
- 4 June 2026
- Contract length
- 12 months
- Ends 31 July 2027